Metabolic Dysfunctions in Amyotrophic Lateral Sclerosis Pathogenesis and Potential Metabolic Treatments
about
Comparison of Sirtuin 3 Levels in ALS and Huntington's Disease-Differential Effects in Human Tissue Samples vs. Transgenic Mouse Models.Brugada syndrome in a patient with amyotrophic lateral sclerosis: a case report.Genetic induction of hypometabolism by ablation of MC4R does not suppress ALS-like phenotypes in the G93A mutant SOD1 mouse model.Quantitative susceptibility mapping of the motor cortex: a comparison of susceptibility among patients with amyotrophic lateral sclerosis, cerebrovascular disease, and healthy controls.Lymphoblastoid cell lines as a model to understand amyotrophic lateral sclerosis disease mechanisms.
P2860
Metabolic Dysfunctions in Amyotrophic Lateral Sclerosis Pathogenesis and Potential Metabolic Treatments
description
2016 nî lūn-bûn
@nan
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
name
Metabolic Dysfunctions in Amyo ...... Potential Metabolic Treatments
@en
Metabolic Dysfunctions in Amyo ...... otential Metabolic Treatments.
@nl
type
label
Metabolic Dysfunctions in Amyo ...... Potential Metabolic Treatments
@en
Metabolic Dysfunctions in Amyo ...... otential Metabolic Treatments.
@nl
prefLabel
Metabolic Dysfunctions in Amyo ...... Potential Metabolic Treatments
@en
Metabolic Dysfunctions in Amyo ...... otential Metabolic Treatments.
@nl
P2860
P356
P1476
Metabolic Dysfunctions in Amyo ...... Potential Metabolic Treatments
@en
P2093
Karin Borges
Tesfaye W Tefera
P2860
P356
10.3389/FNINS.2016.00611
P577
2016-01-01T00:00:00Z